Design Therapeutics, Inc. - Common Stock (DSGN)

Historical Holders from Q1 2021 to Q3 2025

Symbol
DSGN on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
57.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
34.5M
Holdings value
$260M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
94
Number of buys
30
Number of sells
-49
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Design Therapeutics, Inc. - Common Stock (DSGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Light Irrevocable Trust #1 dated April 22, 2019 6.9% $16.3M 3.83M Light Irrevocable Trust #1 dated April 22, 2019 31 Dec 2024
Star Irrevocable Trust #1 dated April 22, 2019 6.9% $16.3M 3.83M Star Irrevocable Trust #1 dated April 22, 2019 31 Dec 2024
Point72 Asset Management, L.P. 5.2% $11.9M 2.94M Point72 Asset Management, L.P. 27 Aug 2025
Logos Global Management LP 4.4% -21.7% $16.3M -$4.8M 2.52M -22.7% Arsani William 14 Nov 2025

Institutional Holders of Design Therapeutics, Inc. - Common Stock (DSGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34.5M $260M +$644K $7.53 94
2025 Q2 34.5M $116M +$265K $3.37 91
2025 Q1 34.5M $133M +$2.13M $3.86 95
2024 Q4 33.5M $206M +$9.37M $6.17 94
2024 Q3 32M $172M +$1.33M $5.38 98
2024 Q2 32.1M $108M +$4.41M $3.35 92
2024 Q1 30.7M $124M -$3.11M $4.03 88
2023 Q4 31.7M $84M -$1.85M $2.65 87
2023 Q3 32.9M $77.6M -$67.8M $2.36 84
2023 Q2 38.8M $244M +$739K $6.30 96
2023 Q1 38.7M $223M -$16.1M $5.77 94
2022 Q4 40.4M $414M -$601K $10.26 81
2022 Q3 39.9M $668M +$24.5M $16.72 76
2022 Q2 38.7M $542M +$9.16M $14.00 70
2022 Q1 38M $614M +$27.8M $16.15 62
2021 Q4 36.2M $773M +$50.2M $21.41 58
2021 Q3 28.3M $415M +$5.82M $14.69 52
2021 Q2 27.8M $546M +$37.1M $19.89 49
2021 Q1 25.8M $755M +$755M $29.90 43